Quasi-bound states in the continuum (qBICs) achieved through symmetry breaking in photonic metasurfaces are a powerful approach for engineering resonances with high quality factors and tunability. However, miniaturization of these devices is limited as the in-plane unit-cell size typically scales linearly with the resonant wavelength. By contrast, polariton resonators can be deeply subwavelength, offering a promising solution for achieving compact devices. Here we demonstrate that low-loss mid-infrared surface phonon polaritons enable metasurfaces supporting qBICs with unit-cell volumes up to 10⁵ times smaller than the free-space volume $$\lambda_{0}^3$$ λ 0 3 . Using 100-nm-thick free-standing silicon carbide membranes, we achieve highly confined qBIC states with exceptional robustness against incident-angle variations, a feature unique among qBIC systems. This absence of angular dispersion enables mid-infrared vibrational sensing of thin, weakly absorbing molecular layers using a reflective objective, a method that typically degrades resonance quality in standard qBIC metasurfaces. We introduce surface-phonon-polariton-based qBICs as a platform for ultraconfined nanophotonic systems, advancing the miniaturization of mid-infrared sensors and devices for thermal radiation engineering.

This review describes our current understanding of the role of the mitochondria in the repurposing of the anti-diabetes drugs metformin, gliclazide, GLP-1 receptor agonists, and SGLT2 inhibitors for additional clinical benefits regarding unhealthy aging, long COVID, mental neurogenerative disorders, and obesity. Metformin, the most prominent of these diabetes drugs, has been called the “Drug of Miracles and Wonders,” as clinical trials have found it to be beneficial for human patients suffering from these maladies. To promote viral replication in all infected human cells, SARS-CoV-2 stimulates the infected liver cells to produce glucose and to export it into the blood stream, which can cause diabetes in long COVID patients, and metformin, which reduces the levels of glucose in the blood, was shown to cut the incidence rate of long COVID in half for all patients recovering from SARS-CoV-2. Metformin leads to the phosphorylation of the AMP-activated protein kinase AMPK, which accelerates the import of glucose into cells via the glucose transporter GLUT4 and switches the cells to the starvation mode, counteracting the virus. Diabetes drugs also stimulate the unfolded protein response and thus mitophagy, which is beneficial for healthy aging and mental health. Diabetes drugs were also found to mimic exercise and help to reduce body weight.